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INTRODUCTION
A major activity at glutamatergic synapses
in the brain is the production of poten-
tially toxic oxygen radicals, in particu-
lar superoxide, by postsynaptic enzymes
such as PGH synthase and by mitochon-
dria. These need antioxidant mechanisms,
such as the local production of antioxidant
molecules (such as glutathione and ascor-
bate) and antioxidant enzymes, for pro-
tection of the neuron and its component
chemicals (Smythies, 1999a,b). There may
be also a further mechanism for antioxi-
dant protection of neurons, that has been
little explored, and that is the O’Brien
cycle. This paper will describe this cycle
and present an hypothesis as to its in vivo
function.
THE FACTS
For a baseline it will be convenient to
give a brief account of the antioxidant
defenses of the glutamate synapse. Here
the main players in the cleft are ascor-
bate (the major hydrophilic extracellular
antioxidant in brain), glutathione (the
major lipophilic antioxidant), carnosine,
and the antioxidant enzyme superox-
ide dismutase (SOD) (Smythies, 1999a).
Reuptake of glutamate by the glutamate
transporter is associated with a match-
ing release of ascorbate into the cleft
(Grünewald, 1993; Rebec and Pierce,
1994). Glutathione and SOD are actively
secreted into the cleft by astrocytes (Stone
et al., 1999). Presynaptic glutamate vesi-
cles also contain the antioxidant peptide
carnosine, which is released along with
glutamate (Boldyrev et al., 1997). Lastly
dopaminergic boutons en passage are
closely border glutamatergic synapses:
stimulation of D2 receptors results in
the induction in the postsynaptic neu-
ron of anti-oxidant enzymes important
for redox cycling including SOD, gamma-
glutamylcysteine synthase, glutathione
synthase, glutathione peroxidase, glu-
tathione S-transferase, and glutathione
reductase (Tanaka et al., 2001; Smythies,
2002).
However, less data is available about the
antioxidant protection of catecholamines
in and around the synapse. In this regard
it is important to note that the major
mode of interneuronal communication by
dopamine is by volume transmission—
dopamine is released directly into the
extracellular space modulated by the
hydrophilic environment of the extracel-
lular matrix (Rice and Cragg, 2008; Fuxe
et al., 2013). Since dopamine is easily oxi-
dized (Smythies, 1999b) this requires an
efficient antioxidant system. There is evi-
dence that this is partly provided by the
hydrophilic molecule ascorbate:
— In the retina, Neal et al. (1999) showed
that the release of ascorbate protects
dopamine from oxidation.
— Using slow-scan voltammetry follow-
ing the injection of ascorbate oxidase
into the rat striatum, Rebec and Wang
(2001) reported a rapid decline in both
ascorbate and behavioral activation.
Within 20min, an ascorbate loss of
50–70% led to a near-total inhibition
of all recorded behavior including
open-field locomotion, approach of
novel objects and social interaction
with other rats.
— Using microdialysis, Morales et al.
(2012) showed that, in the striatum,
ascorbate release prevents dopamine
oxidation. They also found that glu-
tamate release inhibited dopamine
uptake, while dopamine release inhib-
ited glutamate release. However, this
system is exceedingly complex. Hara
et al. (2009) presented evidence that,
under some circumstances involving
cooperation with iron, ascorbate can
act as a pro-oxidant and stimulate the
generation of the highly neurotoxic
hydroxyl radical.
Other than this, there is scant information
of other antioxidant mechanisms in this
system. However, a clue is offered from an
obscure clinical source.
AN UNEXPLAINED CLINICAL
SYNDROME: THE DESFERRIOXAMINE-
PROCHLORPERAZINE COMA
Blake et al. (1985) reported that a combi-
nation of normal doses of the iron chelator
desferrioxamine and the antiemetic D2-
receptor blocker prochlorperazine, given
to two patients with rheumatoid disease
but otherwise normal iron metabolism,
induced a deep coma that lasted for
2 days in one case and 3 days in
the other. Their EEG depicted increased
slow waves. Neither drug in isolation
produces any such effect at any dose.
The same effect was obtained in rats,
with the coma lasting approximately 7 h
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in normal subjects, and some 36 h in
iron-deficient rats. To date, the mecha-
nism producing this phenomenon remains
obscure.
In a previous communication,
Smythies (2011) suggested that this coma
might be caused by disruption of the
O’Brien cycle in the brain. This cycle is
generated by the interaction of super-
oxide, dopamine and iron (Zhao et al.,
1998; Siraki et al., 2000). These workers
demonstrated that, in isolated hepato-
cytes, cycling between ferrous and ferric
iron linked to cycling between the cat-
echolamine (in particular, dopamine)
and its semiquinone—in the presence of
superoxide—forms an effective dismut-
ing system that transforms the superoxide
into water and hydrogen peroxide. This
cycle depends on the presence of free iron,
superoxide and dopamine molecules at the
same microanatomical locus (for back-
ground information see Smythies, 1999b).
Therefore, the question can be asked:
where in the brain could such propinquity
exist?
Iron is a highly reactive molecule,
and the only place within a neuron that
free iron is known to exist is in endo-
somes, where, however, free dopamine is
not to be found. With that said, there
may be an alternate location worthy of
consideration, that being the extracellu-
lar space between neurons. Here, as we
have noted above, dopamine is present
and functioning in its volume transmis-
sion role, as well as superoxide derived
from NADPH-oxidase on the extracel-
lular side of cell membranes (Oakley
et al., 2009), from extracellular microglia
(Zoccarato et al., 2005) and from mito-
chondria (Bao et al., 2009). NADPH-
oxidase is widely distributed in the brain
(Oury et al., 1999). Iron is also present
but is ensconced its carrier molecule,
transferrin. However, the affinity of cat-
echolamines for iron is greater than
that for transferrin, and Sandrini et al.
(2010) have shown that catecholamines
can “steal” ferric iron from transferrin by
forming catecholamine-iron complexes.
Therefore, it is quite possible that the
O’Brien cycle could operate within the
dopamine-containing extracellular space
in the brain.
It is well established that dopamine
oxidation products, such as dopamine
quinone and dopaminochrome, that
play a role in the O’Brien cycle, can be
highly neurotoxic (Smythies, 1999b).
Furthermore, dopamine activates MAO
activity, and that, when in presence of
ALDH2 deficiency, this activation can be
toxic, particularly to mitochondria, due to
the formation of H2O2 and toxic aldehy-
des (Kaludercic et al., 2014). However,
our hypothesis is not concerned with
the neurotoxic role of dopamine and its
quinones (when they are not engaged in
the cycle), but with their role in reducing
toxic levels of superoxide and provid-
ing adequate levels of hydrogen peroxide
(when they are active in the cycle). The
O’Brien cycle merely recycles dopamine
and its quinones with no effect on the
levels of either. Therefore, considerations
of dopamine and dopamine quinone tox-
icity per se lie outside the scope of this
paper.
Another aspect of redox mechanisms at
the dopamine synapse may be related to
its co-transmission with glutamate.Most if
not all dopaminergic neurons in the mid-
brain utilize glutamate as a co-transmitter
(Descarries et al., 2008; Koos et al., 2011).
Activation of dopaminergic neurons elicits
small amplitude postsynaptic glutamater-
gic currents in all spiny pyramidal neurons
in the nucleus accumbens, mediated by
both AMPA and NMDA receptors. This is
accompanied the by simultaneous release
of dopamine. VGluT2 knockout has com-
plex effects on risk-taking behaviors and
anxiety (Koos et al., 2011). These authors
list three possible functions mediated by
this system: (1) various local postsynap-
tic effects, (2) glutamate release from these
terminals may function as a heterosynap-
tic modulator of other inputs, and (3)
the development and/or maintenance of
dopaminergic synapses. In the case of
the third possibility, one detail that may
be implicated consists of the redox fac-
tors described above. An added benefit
to dopaminergic transmission from co-
transmission with glutamate may be the
availability of the extensive antioxidant
resources of the glutamate synapse listed
earlier. In other words, if these neurons
use both dopamine and glutamate as their
transmitters, then the antioxidant mecha-
nisms associated with the glutamate part
may also be available to the dopamine
part.
OUR HYPOTHESIS
Our hypothesis for the cause of the
desferrioxamine-prochlorperazine coma is
predicated on the fact that the brain
has two powerful antioxidant-protective
mechanisms in play that both involve
dopamine. The first mechanism is the acti-
vation of a series of antioxidant enzymes
by the dopamine D2-receptor, which is
blocked by prochlorperazine. The second
is the O’Brien cycle that would collapse
if deprived of iron by desferrioxamine.
The brain may be able to operate in the
absence of either of these mechanisms,
but not both. A series of experiments are
indicated to test this hypothesis. These
would include repeating the rat experi-
ment by Blake et al. (1985) using a range
of dopamine receptor blockers and iron
chelation agents.
The implications of confirming that the
O’Brien cycle is present and active in the
brain are broad, and would extend well
beyond a simple redox function or control
of superoxide toxicity. The main product
of the O’Brien cycle is hydrogen perox-
ide. This molecule is involved in a wide
range of signaling pathways in the brain.
For example:
— Modulation of both GABAergic and
glutamatergic functions (Frantseva
et al., 1998; Sah and Schwartz-Bloom,
1999).
— Blockade of catecholamine and glu-
tamate uptake by synaptic vesicles
(Wang and Floor, 1998).
— Inhibition of synaptic dopamine
release (Chen et al., 2001).
— Inhibition of an adenosine-mediated
synaptic transmission in hippocampal
slices (Masino et al., 1999).
— Maintenance of essential cell popula-
tions in the brain (Dickinson et al.,
2011).
— Modulation of membrane and
cytoskeletal properties in astrocytes
and increasing their intercellular
connections (Zhu et al., 2005).
A general review of this topic is provided
by Rice (2011). Conceivably, the action of
dopamine in the O’Brien cycle might allow
it to modulate the supply of hydrogen per-
oxide for each of these mechanisms. In
and of itself, this would have far-reaching
functional consequences in the context
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of central nervous system physiology and
pathology.
ACKNOWLEDGMENT
We are grateful to Kjell Fuxe for his helpful
input to this paper.
REFERENCES
Bao, L., Avshalumov, M. V., Patel, J. C., Lee, C.
R., Miller, E. W., Chang, C. J., et al. (2009).
The role of hydrogen peroxide in dynamic brain-
cell signaling. Neuroscience 29, 9002–9010. doi:
10.1523/JNEUROSCI.1706-09.2009
Blake, D. R., Winyard, P., Lunec, J., Williams, A.,
Good, P. A., Crewes, S. J., et al. (1985). Cerebral
and ocular toxicity induced by desferrioxamine.
Q. J. Med. 56, 345–455.
Boldyrev, A., Stvolinsky, S. L., Tyulina, O. V.,
Koshelev, V. B., Hori, N., and Carpenter, D. O.
(1997). Biochemical and physiological evidence
that carnosine is an endogenous neuroprotec-
tor against free radicals. Cell. Mol. Neurobiol. 17,
259–271.
Chen, B. T., Avshalumov, M. V., and Rice, M. E.
(2001). H2O2is a novel, endogenous modulator
of synaptic dopamine release. J. Neurophysiol. 85,
2468–2476.
Descarries, L., Bérubé-Carrière, N., Riad, M., Bo, G.
D., Mendez, J. A., and Trudeau, L. E. (2008).
Glutamate in dopamine neurons: synaptic versus
diffuse transmission. Brain Res. Rev. 58, 290–302.
doi: 10.1016/j.brainresrev.2007.10.005
Dickinson, B. C., Peltier, J., Stone, D., Schaffer, D.
V., and Chang, C. J. (2011). Nox2 redox signaling
maintains essential cell populations in the brain.
Nat. Chem. Biol. 7, 106–112. doi: 10.1038/nchem-
bio.497
Frantseva, M. V., Perez Velasquez, H. P., and Carlen,
P. L. (1998). Changes in membrane and synap-
tic properties of the thalamocortical circuitry
caused by hydrogen peroxide. J. Neurophysiol. 80,
1317–1326.
Fuxe, K., Borroto-Escuela, D. O., Romero-Fernandez,
W., Zhang, W. B., and Agnati, L. F. (2013). Volume
transmission and its different forms in the central
nervous system. Chin. J. Integr. Med. 19, 323–329.
doi: 10.1007/s11655-013-1455-1
Grünewald, R. A. (1993). Ascorbic acid in the brain.
Brain Res. Rev. 18, 123–133.
Hara, S., Mizukami, H., Kuriiwa, F., and Endo,
T. (2009). Hydroxyl radical generation depen-
dent on extracellular ascorbate in rat striatum, as
determined by microdialysis. Toxicology 258, 10–6.
doi: 10.1016/j.tox.2008.12.025
Kaludercic, N., Carpi, A., Nagayama, T., Sivakumaran,
V., Zhu, G., Lai, E. W., et al. (2014). Monoamine
oxidase B prompts mitochondrial and cardiac
dysfunction in pressure overloaded hearts.
Antioxid Redox Signal. 20, 267–280. doi:
10.1089/ars.2012.4616
Koos, T., Tecuapetla, F., and Tepper, J. M.
(2011). Glutamatergic signaling by midbrain
dopaminergic neurons: recent insights from
optogenetic, molecular and behavioral stud-
ies. Curr. Opin. Neurobiol. 21, 393–401. doi:
10.1016/j.conb.2011.05.010
Masino, S. A., Mesches, M. H., Bickford, P. C.,
and Dunwiddle, T. V. (1999). Acute peroxide
treatment of rat hippocampal slices induces
adenosine-mediated inhibition of excitatory
transmission in area C1. Neurosci. Lett. 274,
91–94.
Morales, I., Fuentes, A., Ballaz, S., Obeso, J.
A., and Rodriguez, M. (2012). Striatal inter-
action among dopamine, glutamate and ascor-
bate. Neuropharmacology 63, 1308–1314. doi:
10.1016/j.neuropharm.2012.08.007
Neal, M. J., Cunningham, J. R., and Matthews, K. L.
(1999). Release of endogenous ascorbic acid pre-
serves extracellular dopamine in the mammalian
retina. Invest. Ophthalmol. Vis. Sci. 40, 2983–2987.
Oakley, F. D., Abbott, D., Li, Q., and Engelhardt,
J. F. (2009). Signalling components of redox
active endosomes: the redoxosome. Antioxid
Redox Signal. 11, 1313–1333. doi: 10.1089/ars.
2008.2363
Oury, T. D., Card, J. P., and Klann, E. (1999).
Localization of extracellular superoxide dismutase
in adult mouse brain. Brain Res. 850, 96–103.
Rebec, G. V., and Pierce, R. C. (1994). A vitamin as
neuromodulator: ascorbate release into the extra-
cellular fluid of the brain regulates dopaminergic
and glutamatergic transmission. Prog. Neurobiol.
43, 537–565.
Rebec, G. V., and Wang, Z. (2001). Behavioral activa-
tion in rats requires endogenous ascorbate release
in striatum. J Neurosci. 21, 668–675.
Rice, M. E. (2011). H2O2: a dynamic neuro-
modulator. Neuroscientist 17, 389–406. doi:
10.1177/1073858411404531
Rice, M. E., and Cragg, S. J. (2008). Dopamine
spillover after quantal release: rethinking
dopamine transmission in the nigrostriatal
pathway. Brain Res. Rev. 58, 303–313. doi:
10.1016/j.brainresrev.2008.02.004
Sah, R., and Schwartz-Bloom, R. D. (1999). Optical
imaging revelas elevated intracellular chloride in
hippocampal pyramidal neurons after oxidative
stress. J. Neurosci.19, 9209–9217.
Sandrini, S. M., Shergill, R., Woodward, J.,
Muralikuttan, R., Haigh, R. D., Lyte, M., et al.
(2010). Elucidation of the mechanism by which
catecholamine stress hormones liberate iron from
the innate immune defense proteins transferrin
and lactoferrin. J. Bacteriol. 192, 587–594. doi:
10.1128/JB.01028-09
Siraki, A. G., Smythies, J., and O’Brien, P. J. (2000).
Superoxide radical scavenging and attenuation of
hypoxia-reoxygenation injury by neurotransmit-
ter ferric complexes in isolated rat hepatocytes.
Neurosci. Lett. 296, 37–40. doi: 10.1016/S0304-
3940(00)01618-9
Smythies, J. (1999a). Redox mechanisms at the gluta-
mate synapse and their significance: a review. Eur.
J. Pharmacol. 370, 1–7.
Smythies, J. (1999b). The neurotoxicity of glutamate,
dopamine, iron and reactive oxygen species: func-
tional interrelationships in health and disease: a
review-discussion. Neurotox. Res. 1, 27–39.
Smythies, J. (2002). The Dynamic Neuron. Cambridge,
MA: MIT Press.
Smythies, J. (2011). Does the O’Brien cycle
occur in vivo as a key component in
H2O2production and redox signaling? Med.
Hypotheses 76, 299–301. doi: 10.1016/j.mehy.2010.
10.029
Stone, R., Stewart, V. C., Hurst, R. D., Clark, J. B., and
Heales, S. J. R. (1999). Astrocyte nitric oxide causes
neuronal mitochondrial damage, but antioxidant
release limits neuronal cell death. Ann. N. Y. Acad.
Sci. 893, 400–403. doi: 10.1111/j.1749-6632.1999.
tb07865.x
Tanaka, K., Miyazaki, I., Fujita, N., Haque, M. E.,
Asanuma, M., and Ogawa, N. (2001). Molecular
mechanisms of activation of glutathione system
by ropinirole, a selective dopamine D2 recep-
tor agonist. Neurochem. Res. 26, 31–36. doi:
10.1023/A:1007672414239
Wang, Y., and Floor, E. (1998). Hydrogen perox-
ide inhibits the vacuolar H+-ATPase in brain
synaptic vesicles at micromolar concentrations. J.
Neurochem. 70, 646–652.
Zhao, Z. S., Khan, S., and O’Brien, P. J. (1998).
Catecholic iron complexes as cytoprotective super-
oxide scavengers against hypoxia:reoxygenation
injury in isolated hepatocytes. Biochem.
Pharmacol. 56, 825–883.
Zhu, D., Tan, K. S., Zhang, X., Sun, A. Y., Sun,
G. Y., and Lee, J. C. (2005). Hydrogen perox-
ide alters membrane and cytoskeleton properties
and increases intercellular connections in astro-
cytes. J. Cell Sci. 118(pt 16), 3695–3703. doi:
10.1242/jcs.02507
Zoccarato, F., Toscano, P., and Alexandre, A. (2005).
Dopamine-derived dopaminochrome promotes
H(2)O(2) release at mitochondrial complex I:
stimulation by rotenone, control by Ca(2+),
and relevance to Parkinson disease. J. Biol.
Chem. 280, 15587–15594. doi: 10.1074/jbc.
M500657200
Conflict of Interest Statement: The authors declare
that the research was conducted in the absence of any
commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 24 February 2014; accepted: 15 July 2014;
published online: 04 August 2014.
Citation: Smythies J and Edelstein L (2014) The
desferrioxamine-prochlorperazine coma—clue to the
role of dopamine-iron recycling in the synthesis of hydro-
gen peroxide in the brain. Front. Mol. Neurosci. 7:74.
doi: 10.3389/fnmol.2014.00074
This article was submitted to the journal Frontiers in
Molecular Neuroscience.
Copyright © 2014 Smythies and Edelstein. This is an
open-access article distributed under the terms of the
Creative Commons Attribution License (CC BY). The
use, distribution or reproduction in other forums is per-
mitted, provided the original author(s) or licensor are
credited and that the original publication in this journal
is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which
does not comply with these terms.
Frontiers in Molecular Neuroscience www.frontiersin.org August 2014 | Volume 7 | Article 74 | 3
